Nrc Health (NASDAQ:NRC)
| Market Cap | $565.34M+72.7% |
| Revenue (ttm) | $143.79M+3.4% |
| Net Income | $6.44M-60.6% |
| EPS | $0.28-60.0% |
| Shares Out | 21.22M |
| PE Ratio | 88.07 |
| Forward PE | 24.00 |
| Dividend | $0.64(2.40%) |
| Ex-Dividend Date | Dec 29, 2026 |
| Volume | 93,324 |
| Open | $26.87 |
| Previous Close | $26.86 |
| Day's Range | $26.36 - $27.37 |
| 52-Week Range | $11.73 - $27.60 |
| Beta | 0.38 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Feb 2, 2027 |
About NRC
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
Analyst consensus
1 firm rating NRC in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Dec 29, 2026Ex-dividend date
- Feb 2, 2027Earnings report
$NRC stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in NRC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NRC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NRC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New NRC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NRC from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in NRC
| VTIVanguard Morningstar Total Stock Market ETF | $10.56M |
| IWMiShares Russell 2000 ETF | $8.23M |
| DFASDimensional - US Small Cap ETF | $4.25M |
| DESWisdomTree U.S. SmallCap Dividend Fund | $3.37M |
| IWOiShares Russell 2000 Growth ETF | $3.03M |
| DFMCU.S. Micro Cap Portfolio ETF | $2.96M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from NRC’s recent data — informational, not investment advice
